Alzheimer's Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults who are able to understand what the study involves and can give written consent to participate.
• People who have been diagnosed with mild to moderate Alzheimer's disease, or who are in an early stage of Alzheimer's disease with at least one positive biological marker of the condition.
• People aged over 40 years; women must be post-menopausal.
• People who are fluent in Danish.
• People who have completed more than 8 years of standard schooling.
• People who pass a colour blindness test (Ishihara colour test).
• People who have sufficient vision, hearing, and language ability to complete neuropsychological testing.
• People who have a designated caregiver who is available to help with using the study devices at home and can assist with clinic visits and other practical matters.

Who may not be able to join:

• People with significant vision loss that cannot be corrected to an acceptable level with glasses.
• People who have significant abnormalities or lesions in key areas of the brain, such as those involved in vision, decision-making, or memory, as detected by brain imaging before the trial.
• People with a prior history of significant conditions affecting the visual system or the brain.
• People currently taking anti-seizure medications, medications that affect brain function, or high doses of sedatives.
• People with a history of substance misuse within the past two years.
• People with a serious ongoing illness or unstable health condition that could make it difficult to follow the study requirements (as determined by the lead investigator).

Important: Always verify eligibility with the trial site directly before applying.